OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs
Shares of Ocular Therapeutix (OCUL) dropped more than 22% on Monday as investors reacted to upbeat late-stage results from two competitors targeting the same crowded market for longer-lasting wet age-related macular degeneration treatments.The stock is now on track for its worst day since mid-Febru…